Panmure Gordon has been replaced as corporate broker to AIM-listed Horizon Discovery, a biotech company it helped bring to market two years ago.

Horizon said in a statement on April 18 that it had appointed Numis Securities and RBC Capital Markets as its joint corporate brokers. Numis was also named as Horizon's nominated adviser in the statement.